Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
7.53
+0.08 (1.14%)
Apr 1, 2026, 10:51 AM EDT - Market open

Kazia Therapeutics Revenue

Kazia Therapeutics had revenue of 14.66M AUD in the half year ending December 31, 2025, with 209,471,328.57% growth. This brings the company's revenue in the last twelve months to 885.77K, down -93.67% year-over-year. In the fiscal year ending June 30, 2025, Kazia Therapeutics had annual revenue of 1.83M, down -26.30%.

Revenue (ttm)
885.77K AUD
Revenue Growth
-93.67%
P/S Ratio
67.13
Revenue / Employee
147,628 AUD
Employees
6
Market Cap
85.99M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20251.83M-652.76K-26.30%
Jun 30, 20242.48M2.48M248,088.20%
Jun 30, 20231,000.00-24.00K-96.00%
Jun 30, 202225.00K-15.16M-99.84%
Jun 30, 202115.19M14.19M1,426.13%
Jun 30, 2020995.00K-470.43K-32.10%
Jun 30, 20191.47M-11.64M-88.82%
Jun 30, 201813.11M4.30M48.75%
Jun 30, 20178.81M4.74M116.46%
Jun 30, 20164.07M1.23M43.24%
Jun 30, 20152.84M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition